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Antwerp, Antwerp, BelgiumABSTRACT Phosphatidylinositol-4,5-bisphosphate (PIP2) is a phospholipid that has been shown to modulate several ion
channels, including some voltage-gated channels like Kv11.1 (hERG). From a biophysical perspective, the mechanisms
underlying this regulation are not well characterized. From a physiological perspective, it is critical to establish whether the
PIP2 effect is within the physiological concentration range. Using the giant-patch configuration of the patch-clamp technique
on COS-7 cells expressing hERG, we confirmed the activating effect of PIP2. PIP2 increased the hERG maximal current and
concomitantly slowed deactivation. Regarding the molecular mechanism, these increased amplitude and slowed deactivation
suggest that PIP2 stabilizes the channel open state, as it does in KCNE1-KCNQ1. We used kinetic models of hERG to simulate
the effects of the phosphoinositide. Simulations strengthened the hypothesis that PIP2 is more likely stabilizing the channel open
state than affecting the voltage sensors. From the physiological aspect, we established that the sensitivity of hERG to PIP2
comes close to that of KCNE1-KCNQ1 channels, which lies in the range of physiological PIP2 variations.INTRODUCTIONPhosphatidylinositol-4,5-bisphosphate (PIP2) is a phospho-
lipid present in the inner leaflet of the cell plasma membrane
that is implicated in many physiological functions, such as
production of the second messengers inositol trisphosphate
and diacylglycerol, membrane trafficking, cytoskeleton
attachment, and regulation of ion channels and transporters
(1). PIP2 notably regulates several cardiac potassium
channels, such as Kir6.2, Kir2.1, Kv11.1 (hERG), and
Kv7.1 (KCNQ1), implicated in the IKATP, IK1, IKr, and IKs
currents, respectively (2–6). McDonald and co-workers
were the first to describe the PIP2 sensitivity of a voltage-
gated potassium (Kv) channel, hERG (6). This channel,
encoded by the human ether-a`-go-go related gene (hERG,
or KCNH2), is responsible for the rapid delayed rectifier
Kþ current, IKr, in the heart and several other cell types.
In Chinese hamster ovary (CHO) cells expressing hERG
channels, PIP2 application in the pipette led to an increase
in current and a change in activation and inactivation
gating (6).
A key question is the molecular mechanism of this PIP2
regulation. Previous work suggested that this mechanism
was similar in ion channels as various as Kir (inwardly
rectifying potassium) and Kv channels: PIP2 stabilizes the
channel open state of Kir6.2 (7) and the Kv channel
KCNQ1 (8). For KCNQ1 recorded in the inside-out
configuration, this stabilization of the open state resulted
in a slowed deactivation with no effect on activation. It wasSubmitted November 25, 2009, and accepted for publication June 1, 2010.
*Correspondence: gildas.loussouarn@inserm.fr
Editor: Toshinori Hoshi.
 2010 by the Biophysical Society
0006-3495/10/08/1110/9 $2.00surprising to find, in the work by MacDonald and
colleagues, that PIP2 addition (from the pipette on CHO
cells in a whole-cell configuration) led to completely
different effects on hERG biophysical parameters: an accel-
erated activation with no effect on deactivation (6). Two
main hypotheses can be proposed to explain these
differences: 1), the molecular mechanism underlying
Kir6.2 and KCNQ1 modulation by PIP2 does not apply to
hERG channels; or 2), the molecular mechanism underlying
Kir6.2 and KCNQ1 modulation applies to hERG, but the
difference in the biophysical effects of PIP2 is due to the
configuration of the experimental setup (whole-cell in
hERG versus inside-out in KCNQ1). To address this ques-
tion, we studied the effects of PIP2 on hERG under experi-
mental conditions used previously for KCNQ1, mainly the
giant-patch configuration. This configuration is character-
ized by rapid PIP2 depletion after patch excision and allows
direct addition of exogenous PIP2 after this depletion. In this
configuration, hERG and KCNQ1 biophysical changes
induced by PIP2 insertion are quite similar (slowed deactiva-
tion with no effect on activation). We also show that, similar
to the case for KCNQ1, the effects of PIP2 on hERG are
much more convincingly modeled by an influence on
a voltage-independent transition step late in the activation
pathway, suggesting a stabilization of the open state, as in
KCNQ1.
Another key question is whether this PIP2 regulation is
physiologically relevant. A method to gain insight about
this is to study the effects of physiological variations of
PIP2. Indeed, in isolated rabbit cardiac myocytes, a1-adren-
ergic stimulation activates phospholipase C and results indoi: 10.1016/j.bpj.2010.06.013
PIP2 Stabilizes hERG Open State 1111a slight decrease in IKr (6). One limitation to this study was
that activation of a receptor may trigger several regulatory
pathways in parallel (9), sometimes leading to an apparent
PIP2 insensitivity (10). We used several approaches to quan-
tify the channel PIP2 sensitivity, and compared it with the
well-characterized KCNQ1 PIP2 sensitivity (2,5,9). The
results led us to the conclusion that hERG would be sensi-
tive to moderate PIP2 changes in the range of physiological
concentrations, but that at low PIP2 levels, a fraction of
hERG current persists, which may lead to an apparent lower
PIP2 sensitivity compared to that of KCNQ1.METHODS
Cell culture and transfection
The cell line COS-7, derived from the African green monkey kidney, was
obtained from the American Type Culture Collection (CRL-1651,
Rockville, MD) and cultured in DMEM supplemented with 10% serum
and antibiotics (100 IU/mL penicillin and 100 mg/mL streptomycin), all
from GIBCO, (Paisley, Scotland). Cells were transiently transfected
with the plasmids using Fugene-6 (Roche Molecular Biochemical, Indian-
apolis, IN) according to the standard protocol recommended by the manu-
facturer.
hERG cDNA (a kind gift from D. Roden, Vanderbilt University School of
Medicine, Nashville, TN) was subcloned into the mammalian expression
vector pSI (Promega, Madison, WI). The human pCDNA3.1-KCNE1-
KCNQ1 concatemer, human KCNE1 linked to the N-terminus of the human
KCNQ1 (11), is a kind gift from R. S. Kass (The Center for Molecular
Therapeutics, Columbia Presbyterian Medical Center, New York, NY).
The plasmid coding for the green fluorescent protein (pEGFP) used to
identify transfected cells was purchased from Clontech (Palo Alto, CA).
For giant-patch experiments on hERG, relative DNA composition was
60% pSI-hERG and 40% pEGFP (of a total of 2 mg of DNA).
For giant-patch experiments on KCNE1-KCNQ1, relative DNA composi-
tion was 60% pCDNA3-KCNE1-KCNQ1 and 40% pEGFP (of a total of
2 mg of DNA). For giant patch experiments on cotransfected hERG and
KCNE1-KCNQ1, relative DNA composition was 60% pCDNA3-KCNE1-
KCNQ1, 30% pSI-hERG, and 10% pEGFP (of a total of 2 mg of DNA).Electrophysiology
The effect of PIP2 on hERG was studied using the inside-out configuration
of the patch-clamp technique, which allows direct access to the inner leaflet
of the plasma membrane. hERG channels were expressed in COS-7 cells.
To obtain current amplitudes compatible with an accurate determination of
the biophysical parameters, giant patches of membrane (diameter ~10 mm)
were excised.
From 24 to 72 h after transfection, COS-7 cells were mounted on the stage
of an inverted microscope and constantly superfused at a rate of ~2 mL/min.
Experiments were performed at room temperature (235 2C). Acquisition
and analysis were performed using Acquis1 software (Bio-Logic Science
Instruments, Claix, France). Electrodes were connected to a patch-clamp
amplifier (RK-400, Bio-Logic). For giant-patch experiments, the procedure
described in Hilgemann (12) was adapted to excise giant patches from
COS-7 cells. Pipettes were pulled from borosilicate glass capillaries (glass
type 8250, King Precision Glass, Claremont, CA) on a vertical puller (P30,
Sutter Instruments, Novato, CA) and fire-polished using a microforge
(MF-83,Narishige, Tokyo, Japan) to obtain tip diameters of ~10mmfor patch
pipettes and 20 mm for excision pipettes. The excision pipette, filled with the
standard solution, was connected to a 20-mL syringe to apply suction for
excision. A microperfusion system allowed local application and rapid
change of the different experimental solutions (13).Four protocols for hERG currents
Activation protocol. From a holding potential of 100 mV, five voltage
steps (to 85, 70, 55, 40, and þ30 mV) of 2 s each were followed
by a 1-s step at the holding potential, every 16 s.
This protocol facilitated several measurements:
Maximal current, measured as the peak tail current after the þ30 mV
step.
Half-activation potential, where peak tail currents at each potential were










Deactivation time constant at 100 mV, where deactivation time
constants for a single protocol were measured twice, after voltage
steps at 55 mVand 40 mV, and averaged. These values were ob-
tained from a single exponential fit of the tail current after complete
recovery from inactivation (after 1.5 times the time to peak).
Activation time constant at 55 mV, at which potential hERG was not
completely inactivated, allowing accurate measurement of activation
kinetics. The activating current was fitted by a single exponential fit
after inactivation reached a steady state (t> 30 ms after the beginning
of the 55-mV step).
Recovery from inactivation time constant at 100 mV, obtained by
a single exponential fit of the tail current after the þ30-mV step.
The tail current was fitted from the start of repolarization to the peak.
Inactivation protocol. From a holding potential of þ30 mV, 13 hyperpo-
larized voltage steps (from 130 mV to 10 mV in 10-mV increments) of
70 ms each were followed by a 230-ms step at the holding potential. This
protocol enabled characterization of the steady-state inactivation of
hERG from a fully activated/inactivated holding state. The half-inactivation
potential was obtained by a Boltzmann fit of the peak current at each step










Envelope protocol. From a holding potential of 100 mV, 13 depolarized
steps (to 10, 0, 10, or 20 mV) of increasing duration (from 10 ms
to 500 ms). These envelope protocols made it possible to discover the
activation kinetics of hERG otherwise hidden by inactivation at potentials
of 10 mV to 20 mV.
PIP2-Mg2þ and polylysine protocol. From a holding potential
of 100 mV, every 3 s the potential was stepped to 30 mV for 1 s. In
this protocol, the maximal hERG current was measured as the peak tail
current at 100 mV.
Protocol for all KCNE1-KCNQ1 currents
From a holding potential of 60 mV, every 3.5 s the potential was stepped
to þ40 mV for 1.5 s. This protocol was used for the PIP2-Mg2þ and poly-
lysine experiments; the KCNE1-KCNQ1 current was measured as the peak
tail current at 60 mV.
Protocol for hERG and KCNE1-KCNQ1 together during
cotransfection experiments
From a holding potential of100 mV, every 3.5 s the potential was stepped
to þ60 mV for 1.5 s. KCNE1-KCNQ1 current was measured as the current
increase during the step (because of inactivation, hERG current was stable
and very low at this potential, so that any current increase after a few milli-
seconds could be reliably attributed to the activation of KCNE1-KCNQ1
channels). hERG current was measured from the recovery from inactivation
measured during the tail potential (difference between peak tail current andBiophysical Journal 99(4) 1110–1118
1112 Rodriguez et al.current at the beginning of the tail). KCNE1-KCNQ1 alone did not show
any recovery from inactivation (since it does not inactivate) when submitted
to this protocol (data not shown), so that the observed recovery in cotrans-
fection experiments could be reliably attributed to hERG (Fig. S1 in the
Supporting Material).
Statistical significance of the observed effects was assessed by Student’s
t-test (N > 30), Wilcoxon’s test, or two-way ANOVA.Solutions and drugs
For giant-patch experiments, cells were superfused with a standard solution
containing (in mmol/L) 145 KCl, 10 HEPES, and 1 EGTA, pH 7.3 with
KOH. A solution of (in mmol/L) 145 K-gluconate, 10 HEPES, and
1 EGTA, pH 7.3 with KOH, was used to superfuse the cell during Kþ
current measurements and to fill the tip of the patch pipette. PIP2 (Roche
Molecular Biochemicals, Meylan, France) was diluted to 5 mmol/L in
the Kþ current measurement solution and sonicated on ice for 30 min before
application to inside-out patches. 1,2-dioctanoyl-4,5-bisphosphate
(diC8-PIP2) was purchased from Cayman Chemicals (Ann Arbor, MI).
Polylysine 10 kDa was purchased from Sigma-Aldrich (St. Louis, MO)
and dissolved in a 3-mg/mL stock in water.Kinetic models
Three Markov kinetic models were used (see Fig. 3, Fig. S3, and Fig. S4).
They were adapted from previously described hERG models (14–16). For
the model shown in Fig. 3, activation and inactivation are uncoupled and
the hERG current is I ¼ N  g  PO  PNI  (Vm  Vr), where N  g
(N is the number of channels present and g the single-channel conductance)
represents the maximal conductance of the membrane, PO the probability
that the activation gate is in the open state (O), and PNI the probability
that the inactivation gate is in the noninactivated state (NI). Vm is the
membrane potential and Vr the reversal potential of the hERG current.
The same concentration of potassium is applied on both sides of the patch
for all experiments and Vr is set to 0 mV.
Optimization was performed with ModelMaker v4.0 (AP Benson,
Wallingford, United Kingdom) using the Marquardt method. Optimization
was aimed at minimizing the mean square distance between currents
measured for three protocols (see Results) and corresponding simulated
currents. All transition rates had the form a ¼ a1  expða2  VmÞ. a2
was set to 0 mV1 in the case of voltage-independent transitions.
The inactivation transition rates of the model with uncoupled activation/
inactivation (see Fig. 3) and the weakly coupled model (Fig. S3 A) were
determined by two fits (see Fig. S2). The four free parameters (aI1, aI2,
bI1, and bI2) were adjusted to fit the inactivation curve and recovery from
inactivation kinetics:
Irel ¼ 1
1 þ bI1=aI1  expðð  aI2 þ bI2Þ  VmÞ
trec ¼ 1
aI1  expðaI2  VmÞ þ bI1  expðbI2  VmÞ
RESULTS
PIP2 modulation of hERG channels
The effect of PIP2 on hERG was studied using the inside-out
configuration of the patch-clamp technique. For several
channels it has been demonstrated that patch excision results
in a current decrease (rundown) attributable at least partiallyBiophysical Journal 99(4) 1110–1118to a decrease in membrane PIP2 levels, and that PIP2 at least
partially reverses this rundown (8). Consequently, we first
examined the effect of excision and PIP2 application
on the activity of hERG channels. Currents were measured
during three distinct step protocols detailed in the Methods
section. 1), An activation protocol (Fig. 1 A, left) was used
to construct the activation curve (Fig. 1 B, left). Applied
every 16 s, this protocol indicated the evolution of half-
activation potential and deactivation, activation, and
recovery from inactivation kinetics (Fig. 1 C). 2), An
inactivation protocol (Fig. 1 A, middle) was used to
construct the inactivation curve (Fig. 1 B, middle) at specific
time points: after excision (control), after rundown, and
after PIP2 application. 3), An envelope protocol (Fig. 1 A,
right) was used to measure the activation kinetics
(Fig. 1 B, right) at potentials where inactivation masks
activation (10, 0, þ10, and þ20 mV).
Data from a representative patch, on which all protocols
were run, are shown in Fig. 1. The averaged biophysical
parameters measured in the three conditions (control, after
rundown, and after PIP2 application) are shown in Fig. 2.
The currents measured with the three protocols illustrate
the decrease in hERG current ~15 min after excision
(Fig. 1 A). The maximal current decreased below one-
quarter of its initial level within ~10 min (Fig. 1 C), but in
most of the cells, a current persisted after rundown. The
remaining current may correspond to a PIP2-independent
component, or it may be due to residual membrane PIP2
levels. Concomitantly with its rundown, hERG current
showed an acceleration of both the activation and
deactivation kinetics (Figs. 1 C and 2). hERG voltage
dependence of activation shifted by about 18 mV toward
negative potentials. Channel inactivation was also affected:
the half-inactivation potential was shifted by about þ15 mV
toward positive potentials, and recovery from inactivation
was accelerated (Figs. 1, B and C, and 2).
Patch excision may lead to additional changes in the
channel environment than beside PIP2 depletion. To confirm
the PIP2 modulation of hERG, we added 5 mmol/L PIP2
when the biophysical parameters were stable. Within a
few minutes of PIP2 superfusion, the current amplitude
increased but did not reach the initial current level observed
right after excision (Figs. 1 C and 2). Regarding the
activation gate, deactivation slowed down to initial levels.
However, addition of PIP2 did not restore channel activation
kinetics, indicating that the changes in this parameter
observed upon patch rupture are unrelated to the depletion
of PIP2. All these observations (incomplete current
recovery, complete deactivation kinetics recovery, and no
change in activation kinetics) were made previously for
the PIP2 effect on KCNQ1 (8). In that work, the incomplete
current recovery was attributed to a PIP2-independent
rundown that could be prevented by addition of MgATP.
This was not the case for hERG (data not shown). Regarding
inactivation, PIP2 slowed the recovery from inactivation
FIGURE 1 Rundown of hERG and reversal by
PIP2 application. Data from a giant patch of a repre-
sentative COS-7 cell transfected with hERG and
studied in the inside-out configuration. (A) hERG
current in response to an activation protocol
(left), an inactivation protocol (middle), and
an envelope protocol (right). Tail currents are
proportional to the activation of hERG in the first
protocol. Peak currents divided by the electromo-
tive force are proportional to the extent of inactiva-
tion in the second protocol. Peak currents represent
the time course of channel activation in the
envelope protocol. Shown are the control current
after excision (t ¼ 60 s), the current after rundown
(t ¼ 1076 s), and the current after addition of PIP2
(t ¼ 1757 s, 5 mmol/L PIP2 is added at t ¼ 1200 s).
(B) Activation curve (left), inactivation curve
(middle), and time course of the peak inward
current amplitude (right) at 10 mV, obtained
from the recordings shown in A. Activation and
inactivation curves are fitted by Boltzmann equa-
tions. The measurement points (symbols) and fits
(lines) are indicated for control (triangles, solid
line), after rundown (circles, dashed line); and
after PIP2 addition (squares, dotted line). (C)
Kinetics of hERG biophysical parameters during
rundown and after 5 mmol/L PIP2 addition. These
parameters are measured from the activation
protocol repeated every 16 s. Solid symbols indi-
cate maximal current, 100 mV deactivation,
and recovery-from-inactivation time constants;
open symbols indicate half-activation potential
and 55 mV activation time constant.
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toward negative potentials back toward initial control values
(Figs. 1 C and 2).PIP2 favors the open state of the hERG channel
We observed that PIP2 effects on hERG were very close
to those observed on KCNQ1 in the same experimental
conditions (mainly the giant-patch configuration): increased
current, slowed deactivation, and no effect on activation
kinetics. However, the effects of PIP2 on hERG were quite
different if PIP2 was applied in the patch pipette(i.e., accelerated activation and no effect on deactivation)
(6). Altogether, these observations stress the importance of
experimental conditions in studying the effect of PIP2 on
a current. Of most importance, the similarity between the
effect of PIP2 on hERG and that on KCNQ1 suggests
a similar molecular mechanism for this regulation.
Using kinetic models, we showed previously that PIP2
affects the late conformational changes of the KCNQ1 pore
domain leading to channel opening rather than the early
conformational changes implicating S4 movement (8).
We used the same strategy in this study, to explore whether
PIP2 affects the late conformational changes also in hERG.Biophysical Journal 99(4) 1110–1118
FIGURE 2 Biophysical parameters variation for hERG during rundown
and after PIP2 addition. Biophysical parameters are averaged. Maximal
current, half-activation potential, and time constants for deactivation
at 100 mVand activation at 55 mV were obtained from 81–90 patches.
Activation time constants at 10 to 20 mV were obtained from
1423 patches. Half-inactivation potential and recovery from inactivation
time constant at 100 mV were obtained from 27 and 45 patches, respec-
tively. Black bars represent control, measured after excision; light gray bars
represent the current after 5–10 min rundown and before PIP2 addition; and
dark gray bars indicate the current >2 min after PIP2 addition (*p < 0.05).
A Bonferroni correction was applied for multiple comparison between time
constants of activation. There was a significant difference between time
constants of activation measured in control and after rundown, but not
between the after-rundown and after-PIP2 conditions.
FIGURE 3 (A) Kinetic model of hERG currents before and after PIP2
application. Activation and inactivation are modeled as uncoupled
processes. The channel is open when it is in the O and NI states at the
same time. To focus on activation properties, transition rates regarding
inactivation (aI, bI) are determined before and after PIP2 addition from
a concomitant fit of voltage-dependent inactivation rates and recovery-
from-inactivation kinetics (Fig. S2). (B) Simulated and recorded hERG
currents for the three protocols before and after PIP2 application. The tran-
sition rates and biophysical parameters determined from these simulations
are shown in Table S1. Optimization of the late voltage-independent
transitions (aP, bP), supposed to be related to the pore domain, leads to
a reasonable fit of the PIP2 effect that is as good as the fit obtained by
optimizing all transition rates. Conversely, optimization of early voltage-
dependent transition rates (aVS1, bVS1, aVS2, bVS2), supposed to be mainly
related to the voltage sensing of hERG, leads to a poor fit of the PIP2 effect.
1114 Rodriguez et al.In the model used, we hypothesize that the voltage sensor
movements are predominantly described by the early and
voltage-dependent transitions in the activation pathway,
whereas the pore opening is predominantly described by
the late and voltage-independent transition, as suggested
for other channels (8,17).Modification of several biophysical
parameters of hERG implies that the effect of PIP2 cannot be
simply amodification of the number of active channels (since
in that case only the maximal current would be altered). This
observation justifies the need for kinetic models to determine
the transition rates between hERG conformations that are
sensitive to PIP2. We already mentioned that after 10 min
of rundown, hERG biophysical parameters were almost
stable. As a consequence, the modification of hERG current
after PIP2 addition could be mainly attributed to the PIP2
effect. We thus used current recordings after ~15 min of
rundown (before PIP2 addition) and after PIP2 addition
(~10min later) as constraints for our kinetic models. To limit
the number of free parameters, we first used the simplest
model that fitted our data correctly (Fig. 3). In this model,
hERG activation and inactivation processes are uncoupled.
This is consistent with a recent study (18) and makes it
possible to address independently the effect of PIP2 on
channel activation and inactivation. However, the question
of the activation/inactivation coupling being still open, we
also used coupled models (cf. below and the Supporting
Material). To take into account the PIP2 effect on the inacti-
vation process, the transition rates of this process (aI and bI)
were determined before and after PIP2 addition fromBiophysical Journal 99(4) 1110–1118a concomitant fit of the inactivation curve and the voltage
dependency of the kinetics of recovery from inactivation
(Fig. S2). Subsequently, these inactivation kinetics were
fixed, and only the transition rates of the activation process
were optimized to fit our data.
We fitted all the current recordings obtained with the three
different pulse protocols shown in Fig. 1 A. First, transition
rates regarding activation before PIP2 addition were opti-
mized (Table S1) and the current recordings were well fitted
for each protocol (Fig. 3). The biophysical parameters
obtained from the simulations were also close to those
determined from the experiments (Table S1). Second, to
determine which transition rates varied after PIP2 addition,
we optimized separately the values of the transition rates
related to the voltage sensing (early voltage-dependent transi-
tions: aS1, bS1, aS2, and bS2), the transition rates related to the
pore (late voltage-independent transitions: aP, bP), and all the
transition rates regarding activation (aS1,bS1,aS2,bS2,aP, and
bP). The fit obtained by optimizing only the pore transition
rates was reasonably good, almost as good as the fit obtained
by optimizing all the transition rates (Fig. 3). Biophysical
parameters were also determined (Table S1). Modifying the
late transition rates was sufficient to simulate the two main
PIP2 Stabilizes hERG Open State 1115effects of PIP2: increase of maximal current and slowing of
deactivation (Table S1, bold print). On the contrary, optimiza-
tion of the voltage sensor transition rates was unable to fit the
experimental current recordings despite having more free
parameters. These simulations indicated that the effect of
PIP2 on hERG current could be fully explained by a change
of a late and voltage-independent transition rate that is
probably related to the pore, leading to a stabilization of the
open state. We also demonstrated that this conclusion was
valid for other kinetic models of hERG that show weak or
strong coupling between activation and inactivation (see
Discussion and Fig. S3 and Fig. S4); hence, this conclusion
certainly did not result from the choice of an oversimplified
description of hERG.A kinetic model is not an absolute proof
for one or another mechanism, and it is still possible that PIP2
exerts a dual effect both on the pore and the voltage-sensor.
However, these models suggest that a stabilization of the
pore is sufficient to explain the PIP2 effect.hERG presents a PIP2 affinity close
to that of KCNE1-KCNQ1
When studying the PIP2 dependency of a channel, it is impor-
tant to make sure that the affinity is compatible with a physi-
ological regulation by PIP2. A common method is to add the
PIP2 analog diC8-PIP2 on the cytosolic side of themembrane.
This facilitates dose-response measurements and sorting of
the affinities of different channels. We observed that hERGwas only weakly activated by addition of up to 100 mmol/L
diC8-PIP2 on the cytosolic face of the membrane (Fig. S5).
We also noticed that the application of diC8-PIP2 led to an
acceleration of channel deactivation, as opposed to slowing
of deactivation by PIP2, showing that the effect of diC8-
PIP2 on hERG does not reproduce the effect of PIP2.
To quantify the affinity of hERG for PIP2, we used
another approach based on the fact that 1), the PIP2
sensitivity of KCNQ1 is well characterized; and 2), this
sensitivity is proven to be in a physiological range (2,5,9).
We cotransfected hERG and KCNE1-KCNQ1 in the same
cells and measured, in the same patch, current rundown
upon patch excision and recovery after PIP2 addition for
both hERG and KCNE1-KCNQ1. We first compared
channel rundown, which for both currents started immedi-
ately after excision and was concomitant (Fig. 4 B).
A difference, however, was the presence of a PIP2-indepen-
dent fraction of hERG current, as described above. An even
more reliable test was to look at the effect of PIP2 addition,
since PIP2 insertion may be quick, and this avoids the bias of
the KCNE1-KCNQ1 PIP2- independent rundown (8). Both
channels responded at the same time (Fig. 4 B) and thus
appeared to be sensitive to the same range of PIP2 concen-
tration. This was further supported by the correlation in
magnitude of hERG and KCNE1-KCNQ1 current ampli-
tudes in response to PIP2 (Fig. 4 C).
To further compare hERG and KCNE1-KCNQ1 PIP2
affinities, we applied polylysine (3 mg/mL) to shield PIP2FIGURE 4 Concomitant responses to PIP2 of
cotransfected hERG and KCNE1-KCNQ1. (A)
Measured currents of a representative cell
(protocol shown in the inset). hERG current was
computed from the recovery from inactivation
(KCNE1-KCNQ1 does not inactivate); KCNE1-
KCNQ1 current was computed from the current
increase during the prepulse (hERG current is
stable after a few milliseconds at high potential).
Currents are shown after excision (control,
t ¼ 5 s), after rundown (t ¼ 290 s), and after
PIP2 addition (t ¼ 780 s; 5 mmol/L PIP2 is added
at t ¼ 315 s). (B) Kinetics of hERG (solid circles)
and KCNE1-KCNQ1 (open circles) currents of
a representative cell (the same as in A). (Upper
graph) Current amplitudes. (Lower graph) Current
amplitudes after PIP2 addition normalized to their
steady-state values after complete PIP2 effect. (C)
hERG versus KCNE1-KCNQ1 normalized current
amplitudes during PIP2 application (N ¼ 11 cells).
hERG and KCNE1-KCNQ1 currents are normal-
ized to their steady state after PIP2 addition.
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FIGURE 5 Comparison of the polylysine-
induced rundown of hERG and KCNE1-KCNQ1
currents. (A) Time course of hERG and KCNE1-
KCNQ1 current rundown after 3 mg/mL polylysine
application at time 0. hERG current was evaluated
from the peak tail current of a 1-s step at þ30 mV
followed by repolarization at –100 mV repeated
every 3 s (N ¼ 8 cells). KCNE1-KCNQ1 current
was evaluated from the current at the end of
a 1.5-s step at þ40 mV followed by repolarization
at –60 mV repeated every 3.5 s (N ¼ 11 cells).
*p < 0.05; two-way ANOVA. (B) Deactivation
time constants obtained from a monoexponential
fit of the deactivating tail current before (ctrl)
and after the polylysine-induced rundown. For
KCNQ1, deactivation was measured when
a minimal current persisted (hERG, N ¼ 8 cells;
KCNQ1, N¼ 11 cells). **p < 0.01; ***p < 0.001.
1116 Rodriguez et al.negative charges and to accelerate current rundown (5). This
should minimize the bias of the KCNE1-KCNQ1 PIP2-inde-
pendent rundown. Fig. 5 A shows that polylysine-triggered
rundowns were similar in hERG and KCNE1-KCNQ1
within the first 20 s, but that hERG and KCNE1-KCNQ1
then diverged. KCNE1-KCNQ1 reached zero within 60 s,
a time at which a fraction of hERG current persisted. This
suggests a similar PIP2 sensitivity at high open probability,
but a divergent PIP2 sensitivity at low open probability. To
control that polylysine was specifically targeting PIP2, we
checked whether deactivation was accelerated. Indeed, we
observed an acceleration of deactivation similar to that
observed during the spontaneous rundown (compare Figs.
2 and 5 B).
A final approach in comparing hERG and KCNE1-
KCNQ1 PIP2 sensitivity was to apply different concentra-
tions of Mg2þ to control the concentration of available
PIP2 in the membrane patch. It has been shown in Kir
channels that intracellular Mg2þ inhibition is correlated
with the strength of channel-PIP2 interaction (19). Mg
2þ
inhibits the channel by screening the PIP2 negative charge
in a manner similar to that of polylysine, but reversibly
and in a concentration-dependent manner (20). We thus
applied a range of Mg2þ concentrations to a patch—after
addition of PIP2—to obtain a range of available PIP2
concentrations for hERG and KCNE1-KCNQ1 (Fig. 6, A
and B). After stabilization of hERG maximal current,
increasing doses of Mg2þ were applied to chelate PIP2,
and this resulted in an increasing (and reversible) inhibition
of hERG and KCNE1-KCNQ1 currents. Mg2þ dose-res-
ponse curves are shown in Fig. 6 C. The KCNE1-KCNQ1
dose-response curve was close to that of hERG: the half-
maximal inhibitory concentrations (IC50) for Mg
2þ were
4.7 mmol/L and 4.8 mmol/L, with Hill coefficients of 0.8
and 1.0, for hERG and KCNE1-KCNQ1, respectively. To
control that Mg2þ was specifically targeting PIP2, we
checked whether deactivation was accelerated. Indeed, we
observed an acceleration of deactivation similar to that
observed during the spontaneous rundown (compare Fig. 2Biophysical Journal 99(4) 1110–1118and Fig. 6 D). These results indicate that the affinity of
hERG for PIP2 is close to that of KCNE1-KCNQ1 and
that hERG is likely to be sensitive to PIP2 variations in
the same concentration range.
Based on the convergent results of 1), cotransfection
experiments, 2), polylysine effects, and 3), [PIP2] modula-
tion by Mg2þ, we concluded that hERG has a PIP2 sensi-
tivity close to that of KCNE1-KCNQ1 and is thus likely
to respond to physiological changes in PIP2 concentration.
However, experiments with the spontaneous rundown and
with polylysine clearly showed that a fraction of hERG
current is poorly sensitive or insensitive to PIP2, which
may lead to some difference in the channel physiological
regulation.DISCUSSION
This study suggests that the molecular effect of PIP2, that is,
a stabilization of the open state, is applicable to various, if
not all, PIP2-sensitive potassium channels: the pore-forming
subunit of the KATP channel Kir6.2, the voltage-dependent
channels KCNQ1 (Kv7.1), and, as shown in this study,
hERG (Kv11.1). In addition, this study suggests that both
KCNQ1andhERGare regulated byphysiological PIP2 levels.Comparison of the PIP2 effects observed
in the whole-cell and giant-patch configurations
The activating effect of PIP2 on hERG has been demon-
strated in CHO cells using the whole-cell configuration
with PIP2 in the pipette (6) and in rabbit atrial myocytes
submitted to a1A-adrenergic stimulation (21). The effect
was clear but moderate. In this study, the giant-patch exper-
iments on COS cells confirmed the activating effect of PIP2
on hERG and showed that PIP2 could strongly increase
hERG current, notably by increasing its maximal amplitude
by up to three times (Fig. 4 B). The changes in the recovery-
from-inactivation time constant were also qualitatively the
same as those measured in CHO cells using the whole-cell
FIGURE 6 Mg2þ dose response of hERG and
KCNE1-KCNQ1 in the presence of PIP2 (A)
hERG maximal current of a representative cell.
hERG maximal current was evaluated from the
peak tail current of a 1-s step at 30 mV followed
by repolarization at –100 mV repeated every 3 s.
PIP2 was continuously applied. Various concentra-
tions of Mg2þ were added as indicated. (B)
KCNE1-KCNQ1 maximal current of
a representative cell. KCNE1-KCNQ1 maximal
current was evaluated from the current at the end
of a 1.5-s step atþ40mV followedby repolarization
at –60 mV repeated every 3.5 s. Various concentra-
tions of Mg2þ were added as indicated. (C) Mg2þ
dose response data from hERG (N ¼ 10 cells) and
KCNE1-KCNQ1 (N ¼ 8 cells). Hill fits are pre-
sented for hERG (solid line) and KCNE1-KCNQ1
(dashed line). (D) Deactivation time constants ob-
tained from a monoexponential fit of the deactivat-
ing tail current before (control) and after 6 mM
Mg2þ application in hERG (N ¼ 10 cells) and
KCNE1-KCNQ1 (N ¼ 8 cells). **p < 0.01.
PIP2 Stabilizes hERG Open State 1117configuration, with PIP2 dialyzed from the pipette.
However, the observed effect of PIP2 on half-activation
potential and on deactivation and activation time constants
differed largely between the two configurations. Two major
differences between the whole-cell and giant-patch configu-
rations may explain the divergent observations. 1), In the
whole-cell configuration PIP2 is added in excess, causing
an increase in membrane PIP2, whereas PIP2 levels are
decreased in the giant-patch configuration. This may explain
why deactivation is not modified in whole-cell experiments
but is accelerated during rundown and slowed by PIP2 appli-
cation in giant-patch experiments. Deactivation may be at its
maximal level at physiological PIP2 concentrations,
explaining the absence of effect when PIP2 is added in the
pipette. 2), In the whole-cell configuration, it was not
possible to distinguish between diffusion of PIP2 from the
pipette and the dilution of many cytosolic molecules.
In the giant-patch experiments, on the other hand, we
were able to observe that the prominent acceleration of acti-
vation kinetics and the leftward shift of the activation curve
caused by patch excision could not be recovered by PIP2
application, indicating that these processes are unrelated
to PIP2 depletion. In a similar way, it is possible that in
the whole-cell experiments the changes in these two param-
eters are not due to PIP2 depletion but rather to the dilution
of cytosolic factors.The biophysical effects of PIP2 on hERG current
are consistent with a stabilization of the open
state
To explore which state(s) is affected by PIP2, kinetic models
of hERG were evaluated. The ongoing debate on whether or
not channel activation and inactivation are coupled compli-
cates the choice of the best model for testing the PIP2effect (18). Therefore, several scenarios (no, weak, or strong
coupling) were explored. Data from the uncoupled model
are presented above.
The model shown in Fig. S3 is a weak inactivation/
activation coupling model. The coupling is said to be
weak because transition rates of the last activation step
(aP and bP) do not depend on the inactivation state. The
inactivation rates aI and bI were still set by the fit of the
voltage-dependent inactivation rates and recovery from
inactivation kinetics to limit the number of free parameters.
The early voltage-dependent transition rates were also
supposed to be linked to the voltage sensor and the late
voltage-independent step to the pore. Based on the
simulated currents and biophysical parameters (Fig. S3
and Table S2), it still seems likely that the late voltage-inde-
pendent step controlled the PIP2 effect.
The model of Fig. S4 is a classical model of coupled
inactivation. Late transitions are voltage-dependent and
activation and inactivation processes cannot be clearly
distinguished for these transitions. However, the early tran-
sitions may still be linked to the voltage sensor and the late
transitions to the pore. There were no imposed inactivation
parameters for this model. The late, but not the early, tran-
sition changes accounted well for the PIP2 effect. Alto-
gether, all these models support the idea that PIP2 acts on
late transitions and stabilizes the open pore conformation.
In all models (no, weak, and strong coupling), the best fit
to the electrophysiological data was obtained when late
transition rates probably corresponding to pore opening
were optimized. Optimization of the voltage sensor transi-
tion rates resulted in an inadequate fit of the experimental
data. This observation led us to conclude that PIP2 exerts
its effect by acting on a late voltage-independent transition,
favoring the open conformation of the pore domain.
However, since optimizing all transition rates gave anBiophysical Journal 99(4) 1110–1118
1118 Rodriguez et al.equally satisfying result we cannot fully rule out that PIP2
also modulates other transition rates in addition to the late
voltage-independent rate.Physiological relevance of the PIP2 effect
on hERG
To address the difficult question of the physiological
relevance of the PIP2 effect on hERG, it is critical to
evaluate the channel PIP2 sensitivity. To obtain a quantifica-
tion of the sensitivity of a channel to PIP2, addition of
soluble diC8-PIP2 is commonly used (5). To our surprise,
hERG was shown to be weakly sensitive to diC8-PIP2 in
our experiments, most probably because of the channel’s
lower affinity for this short-chain PIP2. Some experimental
data from inward rectifiers show that the maximal effect of
short-chain PIP2 is lower than that of PIP2, suggesting
a lower affinity (22). To explore hERG sensitivity to native
PIP2, we designed three experiments to compare the PIP2
sensitivity of hERG with that of KCNE1-KCNQ1, which
is well characterized: 1), cytosolic PIP2 application on giant
patches presenting both KCNE1-KCNQ1 and hERG
channels showed a concomitant increase in both currents; 2),
polylysine-induced rundown presented similar kinetics for
both channels; and 3), concomitant addition of the
phospholipid and various concentrations of Mg2þ controlled
PIP2 levels, indicating a similar sensitivity of hERG and
KCNE1-KCNQ1 channels to Mg2þ. All these data support
the idea that hERG and KCNE1-KCNQ1 channels have
a similar affinity to PIP2. However, the experiments
performed also shed light on the persistence of a fraction
of hERG current at low PIP2 levels, which may give rise
to a different response to physiological events, leading to
a profound decrease in membrane PIP2 levels.SUPPORTING MATERIAL
Five figures and a table are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(10)00723-X.
We thank Be´atrice Leray, Marie-Joseph Louerat, Sylvie Leroux, and Agnes
Carcoue¨t for expert technical assistance.
This work was supported by grants from the Institut National de la Sante´ et
de la Recherche Me´dicale (INSERM) and from the Agence Nationale de la
Recherche to G.L. and N.R. (ANR-05-JCJC-0160-01) and to I.B.
(ANR COD/A05045GS). G.L. and I.B. are recipients of a tenured position
supported by the Centre National de la Recherche Scientifique (CNRS). J.P.
was supported by the Association Franc¸aise contre les Myopathies (AFM).REFERENCES
1. McLaughlin, S., J. Wang,., D. Murray. 2002. PIP2 and proteins: inter-
actions, organization, and information flow. Annu. Rev. Biophys. Bio-
mol. Struct. 31:151–175.Biophysical Journal 99(4) 1110–11182. Park, K. H., J. Piron, ., G. Loussouarn. 2005. Impaired KCNQ1-
KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction under-
lies the long QT syndrome. Circ. Res. 96:730–739.
3. Huang, C. L., S. Feng, and D. W. Hilgemann. 1998. Direct activation of
inward rectifier potassium channels by PIP2 and its stabilization by
Gbg. Nature. 391:803–806.
4. Hilgemann, D. W., and R. Ball. 1996. Regulation of cardiac Naþ,Ca2þ
exchange and KATP potassium channels by PIP2. Science. 273:
956–959.
5. Zhang, H., L. C. Craciun, ., D. E. Logothetis. 2003. PIP2 activates
KCNQ channels, and its hydrolysis underlies receptor-mediated inhibi-
tion of M currents. Neuron. 37:963–975.
6. Bian, J., J. Cui, and T. V. McDonald. 2001. HERG Kþ channel activity
is regulated by changes in phosphatidyl inositol 4,5-bisphosphate. Circ.
Res. 89:1168–1176.
7. Enkvetchakul, D., G. Loussouarn,., C. G. Nichols. 2000. The kinetic
and physical basis of KATP channel gating: toward a unified molecular
understanding. Biophys. J. 78:2334–2348.
8. Loussouarn, G., K. H. Park,., D. Escande. 2003. Phosphatidylinosi-
tol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated
potassium channels: a functional homology between voltage-gated
and inward rectifier Kþ channels. EMBO J. 22:5412–5421.
9. Matavel, A., and C. M. Lopes. 2009. PKC activation and PIP2 depletion
underlie biphasic regulation of IKs by Gq-coupled receptors. J. Mol.
Cell. Cardiol. 46:704–712.
10. Gamper, N., Y. Li, andM. S. Shapiro. 2005. Structural requirements for
differential sensitivity of KCNQ Kþ channels to modulation by
Ca2þ/calmodulin. Mol. Biol. Cell. 16:3538–3551.
11. Wang, W., J. Xia, and R. S. Kass. 1998. MinK-KvLQT1 fusion
proteins, evidence for multiple stoichiometries of the assembled IsK
channel. J. Biol. Chem. 273:34069–34074.
12. Hilgemann, D. W. 1989. Giant excised cardiac sarcolemmal membrane
patches: sodium and sodium-calcium exchange currents. Pflugers Arch.
415:247–249.
13. Loussouarn, G., I. Baro´, and D. Escande. 2006. KCNQ1 Kþ channel-
mediated cardiac channelopathies. Methods Mol. Biol. 337:167–183.
14. Kiehn, J., A. E. Lacerda, and A. M. Brown. 1999. Pathways of HERG
inactivation. Am. J. Physiol. 277:H199–H210.
15. Clancy, C. E., and Y. Rudy. 2001. Cellular consequences of HERG
mutations in the long QT syndrome: precursors to sudden cardiac
death. Cardiovasc. Res. 50:301–313.
16. Wang, S., S. Liu,., R. L. Rasmusson. 1997. A quantitative analysis of
the activation and inactivation kinetics of HERG expressed in Xenopus
oocytes. J. Physiol. 502:45–60.
17. Gagnon, D. G., and F. Bezanilla. 2009. A single charged voltage sensor
is capable of gating the Shaker Kþ channel. J. Gen. Physiol. 133:
467–483.
18. Choveau, F. S., A. El Harchi,., G. Loussouarn. 2009. Transfer of rolf
S3-S4 linker to HERG eliminates activation gating but spares inactiva-
tion. Biophys. J. 97:1323–1334.
19. Du, X., H. Zhang, ., D. E. Logothetis. 2004. Characteristic interac-
tions with phosphatidylinositol 4,5-bisphosphate determine regulation
of kir channels by diverse modulators. J. Biol. Chem. 279:
37271–37281.
20. Suh, B. C., and B. Hille. 2007. Electrostatic interaction of internal
Mg2þ with membrane PIP2 seen with KCNQ K
þ channels. J. Gen.
Physiol. 130:241–256.
21. Bian, J. S., and T. V. McDonald. 2007. Phosphatidylinositol 4,5-bi-
sphosphate interactions with the HERG Kþ channel. Pflugers Arch.
455:105–113.
22. Roha´cs, T., C. Lopes,., D. E. Logothetis. 2002. Assaying phosphati-
dylinositol bisphosphate regulation of potassium channels. Methods
Enzymol. 345:71–92.
